Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 127-58-2
2. Sulfamerazine Sodium Salt
3. Sodium Sulfamerazine
4. Soluble Sulfamerazine
5. Solumedine
6. Sulfamerazine (sodium Salt)
7. Sulfamerazine Sodium [inn]
8. 2-sulfanilamido-4-methylpyrimidine Sodium Salt
9. Jov4ujy07o
10. Sulfamerazine Monosodium Salt
11. Monosodium 2-sulfanilamido-4-methylpyrimidine
12. 4-methyl-2-sulfanilamidopyrimidine Sodium Salt
13. Benzenesulfonamide, 4-amino-n-(4-methyl-2-pyrimidinyl)-, Monosodium Salt
14. Sulfamerazine, Sodium Salt Monohydrate
15. Nsc-226823
16. Sulfamerazine Sodium [injection]
17. Sodium;4-amino-n-(4-methylpyrimidin-2-yl)benzenesulfonamide
18. Sodium;(4-aminophenyl)sulfonyl-(4-methylpyrimidin-2-yl)azanide
19. Sulfamerazin Natrium
20. Sodium Sulphamerazine
21. Solfamerazina Sodica [dcit]
22. Solfamerazina Sodica
23. Sulfamerazina Sodica
24. Sulfamerazine Sodique
25. Sulfamerazinum Natricum
26. Sulfamerazina Sodica [inn-spanish]
27. Sulfamerazine Sodique [inn-french]
28. Einecs 204-851-0
29. Sulfamerazinum Natricum [inn-latin]
30. Unii-jov4ujy07o
31. Nsc 226823
32. Sulfamerazine Sodium Injection
33. Sulfamerazinnatrium
34. N(sup 1)-(4-methyl-2-pyrimidinyl)sulfanilamide Sodium Salt
35. Sodium Derivate Of N1-(4-methyl-2-pyrimidinyl)sulfanilamide
36. Benzenesulfonamide, 4-amino-n-(4-methyl-2-pyrimidinyl)-, Sodium Salt (1:1)
37. Sulfamerazinesodium
38. Sulfamerazine Sodium [injection] [inn:nf]
39. Schembl2820643
40. Chembl2107260
41. Dtxsid1051644
42. Hy-b0512a
43. Sulfanilamide, N1-(4-methyl-2-pyrimidinyl)-, Monosodium Salt
44. Sodium,(4-aminophenyl)sulfonyl-(4-methylpyrimidin-2-yl)azanide
45. Sulfamerazine Sodium [mart.]
46. Sulfanilamide, N(sup 1)-(4-methyl-2-pyrimidinyl)-, Monosodium Salt
47. Sulfamerazine Sodium [who-dd]
48. Akos015913915
49. At25528
50. Sulfamerazine Monosodium Salt [mi]
51. Db-041864
52. Ft-0631742
53. Sr-01000883950
54. J-005506
55. Sr-01000883950-1
56. Q27281612
57. Methyl2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxylate
58. Sodium (4-aminophenylsulfonyl)(4-methylpyrimidin-2-yl)amide
59. Sodium ((4-aminophenyl)sulfonyl)(4-methylpyrimidin-2-yl)amide
| Molecular Weight | 286.29 g/mol |
|---|---|
| Molecular Formula | C11H11N4NaO2S |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | 286.05004106 g/mol |
| Monoisotopic Mass | 286.05004106 g/mol |
| Topological Polar Surface Area | 95.3 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 365 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Sulfamerazine Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sulfamerazine Sodium, including repackagers and relabelers. The FDA regulates Sulfamerazine Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sulfamerazine Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sulfamerazine Sodium supplier is an individual or a company that provides Sulfamerazine Sodium active pharmaceutical ingredient (API) or Sulfamerazine Sodium finished formulations upon request. The Sulfamerazine Sodium suppliers may include Sulfamerazine Sodium API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sulfamerazine Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sulfamerazine Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sulfamerazine Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sulfamerazine Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sulfamerazine Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sulfamerazine Sodium suppliers with NDC on PharmaCompass.
Sulfamerazine Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sulfamerazine Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sulfamerazine Sodium GMP manufacturer or Sulfamerazine Sodium GMP API supplier for your needs.
A Sulfamerazine Sodium CoA (Certificate of Analysis) is a formal document that attests to Sulfamerazine Sodium's compliance with Sulfamerazine Sodium specifications and serves as a tool for batch-level quality control.
Sulfamerazine Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Sulfamerazine Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sulfamerazine Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Sulfamerazine Sodium EP), Sulfamerazine Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sulfamerazine Sodium USP).
LOOKING FOR A SUPPLIER?
